As a potent inducing agent for IgE production and differentiation factor for allergen-specific cells, IL-4 is a key regulatory cytokfne both in the pathogenesis of allergic disease and in the ongoing allergic response. The assay of In vitro IL-4 production has often been used to compare the allergen responses of T cells Isolated from atopic and non-atopic subjects. Because peripheral blood basophils also have the capacity to respond to specific allergen by producing IL-4, we investigated the relative contribution of these two cell types to IL-4 production in allergenstimulated primary cultures. 
Introduction
IL-4 plays a pivotal role in allergic disease and is a key element in the initiation of atopy. By driving differentiation to the Tn2 phenotype (1, 2) , IL-4 elicits T cell help for antibody production. By directing Ig isotype switch recombination to the C E locus (3), IL-4 provides a necessary signal for generation of the specific IgE which defines allergy. Because allergy is essentially an inflammatory reaction of the skin and of mucosa lining sites of allergen entry, IL-4 produced at the reaction site may also be required for maintaining the ongoing T cell activation that supports the allergic response. The role of IL-4 in allergic reactions has been strengthened by the demonstration of cells expressing IL-4 mRNA localized to the cutaneous sites of developing late phase reactions (4, 5) .
Initially, IL-4 was thought to be produced exclusively by activated T lymphocytes. In recent years, however, evidence has accumulated identifying additional cell types with the capacity to produce IL-4, particularly under conditions associated with atopy. Tissue mast cells, the principal effector cells secreting inflammatory mediators in the immediate phase wheal and flare reaction, may generate high levels of IL-4 at mucosal sites of allergen entry in response to IgE receptor cross-linking (6, 7) . Blood-borne basophils, which are major effector cells of the allergic late phase (8) , can be triggered by allergen to produce IL-4 in addition to histamine and leukotrienes (9) (10) (11) (12) . Recently, it has been suggested that eosinophils may also produce IL-4 in atopic disease (13, 14) . Thus, several cell types with clear involvement in allergic reactions have the ability to secrete IL-4 in response to allergen challenge. Because IL-4 itself is required for T cell differentiation to the IL-4-producing T"h2 phenotype (1, 2) , IL-4 production by allergy effector cells at the site of allergen challenge may not only have direct effects on IgE production by B cells (15) , but may also regulate generation of the allergen-specific 1^2 cells which will maintain the response. In primary cultures of peripheral blood mononuclear cells (PBMC) isolated from atopic and non-atopic subjects, the production of IL-4 has generally been taken as a measure of T cell activation (16) (17) (18) . When primary cultures are established using lymphocytes isolated from allergic subjects and stimulated with allergen in vitro, however, IgE-mediated IL-4 production pathways must be considered. Although basophils comprise 2% or fewer of peripheral blood leukocytes, they can secrete high levels of IL-4 in an allergen-specific, dosedependent manner (9) (10) (11) (12) , and are a potentially important source of this cytokine in vitro and in vivo. Previous reports describing their ability to generate IL-4 in response to IgE receptor cross-linking have utilized totally or partially purified basophils (9) (10) (11) (12) . In this study, we examine the contribution of basophils to overall levels of IL-4 secreted by unfractionated PBMC under conditions of primary culture typically used for the evaluation of T cell responses.
Methods

Antigens
The major allergen of the domestic cat, Felis domesticus 1 (Fel d 1), was isolated from cat hair extract by affinity purification (19) . Goat anti-human IgE was purchased from Kirkegaard & Perry (Gaithersburg, MD), and phorbol myristate acetate (PMA) and ionomycin were purchased from Sigma (St Louis, MO).
Isolation of PBMC and cell culture conditions
Lymphocytes were isolated from 1-day-old heparinized peripheral blood of healthy atopic and non-atopic volunteers. Atopic subjects were not receiving immunotherapy. They were selected on the basis of skin prick test reactivity of 3+ or 4+ (wheal diameter of 8-10 and >10 mm, respectively) to cat skin test extract. The mononuclear cell fraction was isolated by centrifugation over Ficoll using Accuspin System-Histopaque-1077 (Sigma), and washed twice in RPMI 1640 (Gibco, Grand Island, NY) containing 1 mM L-glutamine, 100 U/ml penicillin, 100 ng/ml streptomycin, 50 |iM 2-mercaptoethanol and 2.5% HEPES (Sigma). Cells were plated in a 48-well tissue culture plate in the same medium supplemented with 5% human AB + serum (Sigma) (complete medium) at 3xiO 6 /ml in 1 ml cultures. Cultures were harvested at specified times and centrifuged at 1200 r.p.m. for 10 min to obtain cell-free supernatant which was stored in aliquots at -80°C until assayed for histamine or cytokine levels. Histamine-release assays performed at various times following culture initiation indicate basophil viability for at least 24 h under these conditions (data not shown).
Basophil depletion
PBMC were isolated as described above, washed twice and resuspended in ice-cold PBS without calcium or magnesium containing 1% BSA (Sigma). Some cells were used without further manipulation as controls for the depletion protocol (control cells). The remaining cells were divided equally into two populations and 1 ng/ml of biotinylated affinity-purified goat IgG anti-human IgE (Kirkegaard & Perry) was added to one sample (basophil-depleted) but not the other (mock-depleted). Both samples were incubated at 4°C for 30 min with gentle rocking, then washed twice with ice-cold 1% BSA. Both samples were resuspended in 1% BSA containing 3xiO 7 /ml magnetic beads coated with streptavidin (Dynabeads M280; Dynal, Lake Success, NY) and incubated for 45 min at 4°C with gentle rocking. The beads were washed twice in ice-cold calcium, magnesium-free PBS containing 1% human AB + serum. IgE receptor-bearing cells (basophils) specifically bound to the beads were depleted by adherence of the bead suspension to a magnet. Unbound cells were washed and resuspended at 3x10 6 /ml in RPMI containing 5% human AB + serum. Cultures were established as described above.
Cytokine assays
IL-2 and IL-5 were analyzed using Quantikine ELISA kits from R&D Systems (Minneapolis, MN). IL-4 was analyzed using an ultrasensitive human IL-4 ELISA kit (Biosource International, Camarillo, CA). Standard curves used to quantitate cytokine levels in duplicate samples were run with recombinant cytokine provided by the manufacturer diluted into RPMI containing 5% human AB + serum. The ranges of sensitivities of the cytokine ELISA kits, as reported by the manufacturers, were 6-2000 pg/ml for IL-2, 1-500 pg/ml for IL-5 and 65-25,000 fg/ml for IL-4. Responses above these minimum levels were considered positive. Samples that would potentially exceed the levels of the assay standards were diluted and quantitated appropriately. Assays were performed on supernatant thawed only once.
Histamine release assay
Histamine levels in cell supernatants were quantitated by glass fiber assay, using 96-well plates containing glass microfibers (Reference, Copenhagen, Denmark). Cell supernatants were incubated in the plates overnight at 4°C, allowing histamine to bind to the glass fibers. The plates were washed with distilled water, followed by 1 h incubation at 37°C with 0.4% SDS. The histamine was eluted from the wells with sodium hydroxide and derivitized with o-phthaldialdehyde (OPT; Sigma) for 10 min at room temperature to yield a fluorescent product. The reaction was terminated with 0.30% perchloric acid, and fluorescence quantitated using an auto-sampler and fluorometer, as described (20) . Histamine levels were quantitated by comparison to a standard curve generated by coupling histamine dihydrochloride (Sigma) to OPT. The assay was sensitive to 1 ng/ml histamine. For determination of total cellular histamine (maximum release), the cells were placed in a bath of boiling water for 3 min to disrupt basophils. Cells and cell debris were pelleted by centrifugation for 5 min at 10,000 r.p.m. and histamine levels in the supernatant assayed as above.
Proliferation assays
Cells were plated in complete medium in triplicate wells of a 96-well flat-bottom plate at 2xiO 5 Avell and challenged with the appropriate antigen. On day 6 (unless otherwise speci- Cultures were terminated by freezing the plates at -20°C; after thawing, the cells were harvested onto glass fibre filtermats (Wallac, Gaithersburg, MD) using a plate harvester (Tomtec, Orange, CT). Mats were treated with Beta Plate Scint (Fisons Chemicals, Loughborough, UK) and [ 3 H]thymidine incorporation in each well was quantitated using a 1205 Betaplate liquid scintillation counter (Wallac). Average c.p.m. were determined for each set of triplicates. Responses >2-fold above background in the absence of antigen were considered positive.
Flow cytometry
Cells were stained with FITC-labeled mouse anti-human CD4 (Ortho Diagnostic Systems, Raritan, NJ), phycoerythrin (PE)-labeled mouse anti-human CD8 (Ortho), PE-labeled mouse anti-human CD19 (Ortho) or FITC-labeled mouse anti-human CD14 (Becton Dickinson Immunocytometry Systems, San Jose, CA). FITC-and PE-stained lgG2a murine antibodies (Ortho) were used as isotype controls. Cells from control, mock-depleted and basophil-depleted populations were resuspended in wash buffer containing 5% FCS and 0.01% sodium azide and stained for 30 min at room temperature with labeled antibody. Cells were then washed twice in 0. 5 24 Time of Culture (Hours) 
Results
IL-4 production by allergen-stimulated primary cultures follows a time course distinct from lymphocyte proliferation and IL-5 production
PBMC isolated from five cat-allergic subjects were stimulated with either a low dose (10 ng/ml) or a high dose (10 ng/ml) of the major cat allergen, Fel d 1. After 1, 2, 4 and 6 days of culture, levels of IL-4 and IL-5 in the supernatants were quantitated using specific ELISAs, and cell proliferation was assayed as incorporation of [ 3 H]thymidine. Results with three representative donors (Fig. 1) show that IL-4 production was induced by both the high and low dose of allergen, whereas IL-5 production required exposure to the high dose of Fel d 1. In response to either 10 ng/ml or 10 |ig/ml allergen, IL-4 levels were highest in the supernatants after 1-2 days of culture, and were decreased by days 4-6. In contrast, in response to 10 ng/ml Fel d 1, both IL-5 production and cell proliferation were marginal until day 2 and the maximum response was seen on days 4-6 (Fig. 1) . Thus, the time course for IL-4 production differed from the time courses for both IL-5 production and proliferation of allergen-stimulated PBMC.
These results indicated that IL-4 production by allergenstimulated PBMC occurred within the first 24 h of culture. In order to examine the time course in greater detail, we established cultures at the low dose of Fel d 1 (10 ng/ml) and assayed supernatants at 30 min, 3 h and 24 h. Parallel cultures were stimulated with 100 ng/ml anti-lgE. This experiment addressed the possibility that the rapid production of cytokine was a consequence of IgE receptor cross-linking. Anti-lgE was able to stimulate IL-4 production by these cultures, indicating that IL-4 production could be activated in an IgEdependent manner (Fig. 2) . The maximum IL-4 production was seen at the 3 h time point for all three PBMC samples, with some IL-4 still detectable at 24 h. This is consistent with the time course of IL-4 production by activated basophils (10-12), but not with the typical activation requirements of allergen-specific T cells (17, 18) . The rapid time course and lack of correlation with IL-5 production and proliferation responses suggest that the IL-4 may be produced by non-T cells. The effectiveness of anti-lgE in stimulating the cultures is consistent with IL-4 production by basophils
Allergen dose-response for IL-4 production by primary cultures: peak production at low-dose allergen
Results shown in Fig. 1 indicated that IL-4 production by allergen-stimulated primary cultures could be seen at relatively low doses of allergen (ng/ml). Because we have observed that basophil responses to allergen typically occur at lower doses than T cell responses, we sought to further define the dose requirement for IL-4 production in these cultures. Parallel cultures were stimulated with 10~2 to 10 4 ng/ ml Fel d 1 and 1-10 3 ng/ml anti-lgE. In order to assess the degree of basophil activation under these conditions, culture supernatants were assayed for histamine content in addition to IL-4 levels. Our findings confirmed that IL-4 production peaked at relatively low doses of allergen, between 0.1 and 1 ng/ml Fel d 1 for PBMC isolated from different subjects (Fig. 3) . In each case, IL-4 production was also observed after stimulation with anti-lgE, again demonstrating an IgE receptor-mediated pathway. The dose-response for histamine release corresponded roughly to that for IL-4 production, with the maximum IL-4 response occurring at ~ 10-fold lower allergen concentration than maximum histamine release.
Depletion of basophils from PBMC cultures eliminates allergen-specific IL-4 production
In order to determine the contribution of basophils to the overall levels of IL-4 produced by allergen-stimulated primary cultures, basophils were specifically depleted from the PBMC using biotinylated anti-human IgE and streptavidin-coated magnetic beads. Because basophils typically comprise 2% or less of PBMC in our preparations, their depletion would be difficult to demonstrate by cell staining or flow cytometric methods. Therefore, the efficiency of basophil depletion was monitored in each case by assaying the total histamine content of the PBMC preparation, following disruption of the cells in a boiling water bath. PBMC from 18 subjects were analyzed for total histamine content following the basophil depletion protocol, with depletion efficiencies ranging from 85 to >98%. Typical results with four donors are shown in Fig. 4(A) . Mock-depletions, performed in the absence of specific antibody (Fig. 4A ) or in the absence of magnetic beads (data not shown), confirmed that the depletion protocol did not result in non-specific depletion or degranulation of basophils. Consistent with the extensive depletion of total cellular histamine, primary cultures established with the depleted cell populations failed to show histamine release in response to either allergen or anti-lgE. These cultures also failed to produce IL-4 upon stimulation with either allergen or anti-lgE. Representative results following Fel d 1 stimulation are shown in Fig. 4(B) .
To address the possibility that the basophil depletion protocol may have resulted in the loss of other cell types capable of producing or supporting the production of IL-4 in these cultures, we analyzed the lymphocyte content of basophildepleted and mock-depleted cell populations by flow cytometry. As shown in Table 1 
Basophil-depleted lymphocytes can produce IL-4 in response to mitogen stimulation
Exposure to phorbol ester (PMA) in the presence of ionomycin delivers a potent activation signal that induces IL-4 production by both T cells and basophils (1, 16 "Cells were stained with fluorescent antibodies to CD4 or CD8 (T cells), CD14 (monocytes) and CD19 (B cells) and analyzed by flow cytometry.
b The control cell population consisted of whole PBMC The basophil-depleted cell population was obtained by negative selection using blotlnylated antl-lgE and streptavidm-coated magnetic beads, as described in Methods Mock-depleted cells were subject to the same experimental manipulations in the absence of anti-lgE.
c Background staining (isotype control) was subtracted from the percentage of cells staining for each surface marker with basophil-depleted populations produced less IL-4 in response to PMA and ionomycin than those established with mock-depleted cells ( Table 2 ). The degree of discrepancy was variable for each patient and seemed roughly related to the ability of the cultures to produce IL-4 in response to allergen (from high to low: donors 1897, 2229, 2426 and 400; Fig. 4 ). Because comparable decreases were not seen in mitogen-induced IL-2 production (Table 2) or allergen-stimulated IL-5 production (data not shown) following basophil depletion, the decreased IL-4 levels probably reflect the contribution of basophils to overall IL-4 production in the starting cell population.
PBMC isolated from non-atopic subjects do not produce IL-4 in response to allergen
With our sensitive assay system capable of detecting IL-4 in short-term allergen-stimulated cultures, we have demonstrated IL-4 production by basophils under conditions in which there is no detectable T cell-derived IL-4. To further support that the IL-4 detected in these allergen-stimulated cultures originated from basophils and not T cells, we compared cytokine production by PBMC of atopic and non-atopic subjects. If the IL-4 were produced by basophils, allergenspecific IgE would be required and PBMC isolated from nonatopic subjects should not respond. Because both atopic and non-atopic subjects have detectable titers of total circulating IgE (21), anti-lgE should trigger histamine release and IL-4 production by the basophils of both groups. When PBMC isolated from non-atopic subjects were tested in primary culture, there was no detectable IL-4 generated in response to allergen. In contrast, anti-lgE did induce IL-4 production (Fig. 5) , consistent with a basophil source.
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In order to evaluate the relative contribution of T cells and basophils to overall levels of IL-4 secreted in response to allergen, we established primary cultures of lymphocytes isolated from atopic subjects challenged in vitro with the major cat allergen, Fel d 1. IL-4 was generated rapidly in these cultures, within the first 3 h. It was produced optimally at relatively low doses of allergen, corresponding to those required for IgE-mediated basophil histamine release, but lower than those necessary for optimal T cell IL-5 production or lymphocyte proliferation. Comparable levels of IL-4 could be demonstrated in primary cultures stimulated with anti-lgE or with allergen, indicating that IL-4 could be produced in an IgE-dependent manner. Consistent with an IgE-dependent pathway, PBMC isolated from non-atopic subjects, who lack allergen-specific IgE, did not produce IL-4 in response to allergen, whereas PBMC isolated from each atopic subject tested secreted measurable IL-4. Although they could not respond to allergen, the non-atopes did generate IL-4 after treatment with anti-lgE, confirming the presence of a functional IgE-dependent pathway for IL-4 production. Finally, the demonstration that depletion of basophils from the PBMC eliminated the generation of detectable IL-4 not only confirms the producing cell type as basophils, but further suggests that T cells do not secrete appreciable quantities of IL-4 in allergen-stimulated short-term primary cultures.
The demonstration that PBMC can produce IL-4 in an IgEdependent manner and that depletion of IgE receptor-bearing cells greatly decreases IL-4 production implies that basophils are the source of IL-4 in allergen-stimulated primary cultures. The capacity of basophils to generate IL-4 in an IgEdependent manner has been conclusively demonstrated by numerous studies using enriched or purified basophil preparations (9) (10) (11) (12) . In unfractionated PBMC, however, the possibility exists that eosinophils contribute to the IgE-dependent production of IL-4. Human peripheral blood eosinophils have the capacity to produce IL-4 (13, 14) and can express the highaffinity IgE receptor (22) , although direct IgE-mediated IL-4 production by eosinophils has yet to be demonstrated. In the studies reported here, the dose dependence of IL-4 production correlated with that for histamine release and the depletion of histamine-releasing cells was associated with loss of the IL-4-producmg cell type. While a role for eosinophils cannot be ruled out, these observations are most consistent with the characterization of basophils as the major IL-4 producers in these cultures.
Because each basophil expresses surface receptors for IgE, IL-4 production resulting from IgE receptor cross-linking could potentially involve the entire basophil population, which comprises up to 2% of PBMC in our preparations. This number exceeds by at least 10-to 100-fold the frequency of specific T cells capable of secreting IL-4 in response to allergen challenge. Among atopic subjects, the frequency of house dust mite allergen-specific T cells has been reported to range from 1 in IChMO 4 PBMC (1 in 600-6000 T lymphocytes) (23, 24) . For the major cat allergen, Fel d 1, the frequency of allergen-specific T lymphocytes has been estimated at ~1 in 4x10" PBMC (C. Counsell, unpublished observations). In the current experiments, cultures were established with 3X10 "Patients were treated with PMA (10 ng/ml) and ionomycin (1 (iM) for 24 h. Cytokine production was assayed by specific ELISA ''Cultures were depleted of basophils by negative selection using biotinylated antJ-lgE and streptavidin-coated magnetic beads, as described in Methods. Mock-depleted cultures were subject to the same manipulations in the absence of anti-lgE.
c Percent depletion was calculated by comparison of total histamine levels released from cells following disruption by boiling. Background histamine levels (media controls) were subtracted from total histamine values IL-4 production by basophils in primary culture 1295 PBMC and therefore should have contained several allergenspecific T lymphocytes. Their presence was suggested by the production of allergen-induced IL-5 in these primary cultures. In other studies, CD4 + T cells have been shown to be the source of IL-5 produced in allergen-stimulated primary culture under conditions similar to those utilized here (25) . Basophil depletion experiments resulted in complete loss of detectable allergen-induced IL-4, although the CD4 + and CD8 + T cell subsets were maintained in depleted cultures, and cells capable of IL-4 release following mitogen activation were clearly still present. Mitogen-induced IL-2 secretion and allergen-stimulated IL-5 production were also maintained (data not shown), demonstrating that cytokine-producing T cells were retained following basophil depletion. Taken together, these observations indicate that T lymphocytes capable of cytokine production were present in our cultures but did not respond to allergen with the generation of appreciable quantities of IL-4.
When activated, human mast cells can generate numerous cytokines, including IL-4 and IL-5 (7, 26) . Although this raises the possibility that basophils may also be capable of IL-5 production, no such activity of basophils has, to our knowledge, been described. The IL-5 detected under the experimental conditions described in this report is unlikely to be basophil-derived not only because it was retained following basophil depletion (data not shown), but also because its production required a higher dose of allergen and exhibited delayed kinetics compared to basophil responses. These observations are consistent with a T cell source for the IL-5 detected in these primary cultures. Because both IL-5 and IL-4 are products of activated 1^2. cells, the detection of T cell-derived IL-5 but not IL-4 may reflect such factors as the relative instability of IL-4, lower levels of IL-4 synthesis or greater IL-4 consumption as compared to IL-5. Alternatively, the T h 1/T h 2 paradigm, which can be viewed as a generalized rather than intractable profile of T cell responses (27) , may not be strictly followed in this situation. Although the traditional view is that a given T h 2 cell would have the capacity to secrete both cytokines, recent studies indicate that IL-4 and IL-5 may not be synthesized by the same cell following primary stimulation in vitro (28) . In support of this view, direct TCR-mediated activation of freshly isolated, naive CD4 + T cells resulted in secretion of IL-5 and IL-13, but not of IL-4. Repeated antigenic stimulation, however, did induce coexpression of IL-4 and IL-5 (29), and was required for release of IL-4 by purified CD4 + T cells of atopic subjects (30) . Thus, in short-term cultures responding to low doses of allergen, primary T cell activation can be detected as IL-5 production, but basophils appear to be the principal producers of IL-4.
Our demonstration of basophil-derived IL-4 in allergenstimulated PBMC cultures was very likely due to the high sensitivity of the IL-4 ELISA that was used, as the IL-4 levels generated (typically <10 pg/ml) would not have been detectable by conventional IL-4 assay systems. These findings strongly support the possibility that basophils are major contributors to IL-4 produced in vivo during the allergic response. There is abundant evidence that T lymphocytes also generate IL-4 in vivo during systemic allergic reactions (4, 5, 31) and in vitro following secondary allergenic stimulation (32) (33) (34) . IL-4-secreting T cell lines and clones have been consistently established from the peripheral blood of both atopic and non-atopic donors following several rounds of allergenic stimulation in vitro (35) (36) (37) . In contrast to our observation of rapid IL-4 production, cultures established with freshly isolated PBMC and activated by T cell-directed stimuli produce IL-4 with kinetics that are delayed, peaking within 3-4 days of exposure to polyclonal T cell activators (17) or after 8-10 days of antigenic stimulation (18) . Our findings do not exclude a role for T cells in the production of IL-4 after allergen challenge. Instead, by documenting the contribution of basophils to overall levels of IL-4 secretion, they emphasize the distinct features of cytokine production by these two cell types in terms of kinetics and allergen dose requirements.
In response to allergen challenge, the production of IL-4 is a key event both in the generation of allergen-specific IgE and in the activation of allergen-specific T helper lymphocytes. It is conceivable that in the absence of this cytokine, an IgE immune response, and allergy, would not develop (38, 39) . Thus, the cell types responsible for IL-4 secretion after allergen exposure exert a major controlling influence over the type and extent of the ensuing immune response. Basophils are the principal source of inflammatory mediators in the allergic late phase response and activated T lymphocytes are key components of late phase reactions (8, (40) (41) (42) . The current observations that basophils generate IL-4 prior to the activation of T cells in primary culture would be consistent with a model of coordinate activation, whereby basophil-derived IL-4 could potentiate T cell responses to allergen. The ability of circulating basophils to generate IL-4 rapidly upon exposure to very low quantities of allergen suggests that they could play a role in initiating the T h 2 response to allergen, restimulating memory T cells, or prolonging the immune response when allergen levels drop below those necessary for direct stimulation of T lymphocytes. By delineating the contribution of basophils to IL-4 synthesis in response to allergen, the current findings raise questions about the influence of non-T cell-derived IL-4 on the induction of T cell responses both in vitro and in vivo.
